Last reviewed · How we verify
MatriPlax
At a glance
| Generic name | MatriPlax |
|---|---|
| Also known as | Placenta choriodecidual membrane-derived mesenchymal stem cells |
| Sponsor | BioSpring Medical Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety, Tolerability, and Efficacy of MatriPlax in Subjects With Acute Respiratory Distress Syndrome (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |